Health Canada grants marketing authorisation with conditions for Gilead's Veklury (remdesivir) for the treatment of coronavirus disease 2019 (COVID-19)

28 July 2020 - Veklury is the first approved treatment option for COVID-19 in Canada. ...

Read more →

Spravato (esketamine) nasal spray is available for Canadian patients

22 July 2020 - A new anti-depressant with a novel mechanism of action to treat major depressive disorder in adults. ...

Read more →

Xenleta (lefamulin) receives Health Canada approval for treatment of community acquired pneumonia

16 July 2020 - Nabriva Therapeutics announced today that its partner, Sunovion Pharmaceuticals, has received approval from Health Canada to market ...

Read more →

Sarclisa (isatuximab for injection) now available in Canada for patients with relapsed and refractory multiple myeloma

8 July 2020 - First and only anti-CD38 antibody in combination with pomalidomide and dexamethasone to be approved in Canada. ...

Read more →

Astex Pharmaceuticals, Taiho Oncology and Otsuka Pharmaceutical announce Health Canada approval of Inqovi (decitabine and cedazuridine) tablets, oral hypomethylating agent therapy for intermediate and high-risk MDS and C

7 July 2020 - Inqovi is the first orally administered hypomethylating agent approved by the FDA and Health Canada. ...

Read more →

Deciphera announces Health Canada’s authorisation of Qinlock (ripretinib) for the treatment of fourth-line gastro-intestinal stromal tumour

22 June 2020 - Qinlock significantly improved progression-free survival and showed clinically meaningful overall survival in global INVICTUS Phase 3 study. ...

Read more →

Health Canada Approves Xtandi (enzalutamide) for the treatment of metastatic castration-sensitive prostate cancer

16 June 2020 - Xtandi is the first and only androgen receptor-axis-targeted therapy approved by Health Canada in three clinical ...

Read more →

Sunovion announces Health Canada approval of Kynmobi (apomorphine hydrochloride) soluble film for the treatment of Parkinson's disease OFF episodes

15 June 2020 - First and only sublingual therapy approved for the on-demand treatment of Parkinson’s disease OFF episodes. ...

Read more →

Health Canada issues notice of compliance for Bausch Health's Duobrii

11 June 2020 - Topical combination improving the sings and symptoms of plaque psoriasis in adult patients with moderate to ...

Read more →

Sandoz Canada receives Health Canada approval to launch two oncology biosimilars: Ziextenzo and Riximyo

9 June 2020 - These two approvals mark an important milestone for Sandoz Canada, bringing its biosimilars into oncology at a ...

Read more →

Health Canada advises Canadians to help support the continued supply of medications

1 June 2020 - Health Canada recognizes that drug shortages can have a significant impact on patients and health care ...

Read more →

Health Canada approves birth control arm implant Nexplanon

26 May 2020 - A popular birth control implant that has long been advocated for use in Canada has now ...

Read more →

Rockwell Medical files new drug submission with Health Canada for marketing approval of Triferic AVNU

26 May 2020 - Rockwell Medical today announced the filing of a new drug submission with Health Canada for Triferic AVNU ...

Read more →

Ofev (nintedanib) now available in Canada for adults living with progressive fibrosing interstitial lung diseases

25 May 2020 - Ofev slowed lung function decline in PF-ILD patients by 57% compared to placebo. ...

Read more →

Mithra and Searchlight Pharma announce filing of new drug submission for Estelle in Canada

20 May 2020 - Searchlight Pharma's new drug submission for a novel combined oral contraceptive accepted for review by Health Canada. ...

Read more →